Assessment of the Safety and Efficacy of Dupilumab in Children with Asthma (Liberty Asthma Excursion) - Trial 2017-003317-25
Access comprehensive clinical trial information for 2017-003317-25 through Pure Global AI's free database. This phase not specified trial is sponsored by Sanofi-aventis recherche & développement and is currently status unknown. The study focuses on Asthma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Sanofi-aventis recherche & développement
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
-Any chronic lung disease other than asthma (eg, cystic fibrosis, bronchopulmonary dysplasia) which may impair lung function.
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2017-003317-25
Non-Device Trial